A study of some antiparasitic properties of several homoallylamines and related tetrahydroquinolines and quinolines, previously described, was carried out using in vitro activity assays against the epimastigote form of Trypanosoma cruzi and against Trichomonas vaginalis. Unspecific cytotoxicity against murine macrophages was also studied. Although the antichagasic and trichomonacidal activities are not comparable to those of the standard drugs, nifurtimox and metronidazole, some of the compounds exhibit an interesting specific antiparasitic activity.
Introduction
Parasitic diseases are among the most widespread of human diseases. In 1997, of a global total of 52.2 million deaths, 17.3 million were due to infectious diseases, followed by circulatory diseases, cancer, and respiratory diseases (Tracy and Wester 2001) . American trypanosomiasis, caused by the protozoan parasite Trypanosoma cruzi, is widespread in Latin America, where 16 to 18 million people are estimated to be infected (Organización Panamericana de la Salud 1994) . Since the beginning of the 1970s, benznidazole and nifurtimox have been used for the treatment of Chagas disease, although the commercialization of nifurtimox has been discontinued in Brazil, Argentina, Chile and Uruguay. Controversial results to the use of both drugs are well known and have been recently reviewed (Coura and de Castro 2002) . Clinical phase of Chagas disease, parasite strain, period of treatment, dose, age and geographical origin of the patients (Andrade et al. 1985 , Filardi and Brener 1987 , Toledo et al. 1997 are the main factors responsible for the different degrees of success achieved. This variable susceptibility, side effects and contraindications for benznidazole and nifurtimox treatment, reinforce the need to find more efficient and less toxic drugs.
On the other hand, trichomoniasis is a common, sexually transmitted infection that affects about 170 million of people worldwide, more than the combination of infections produced by gonorrhea, syphilis, and chlamydia (World Health Organization 1995). The 5-nitroimidazole drugs, of which metronidazole is the most prescribed, are the only approved, effective drugs to treat trichomoniasis. Resistance against metronidazole ( Dunne et al. 2003 ) is frequently reported, and crossresistance among the family of 5-nitroimidazole drugs is also common. Moreover, resistant organisms are cosmopolitan in distribution and are of considerable concern as Trichomonas infection are linked to vaginal HIV transmission Kerndt 1998, Lo et al. 2002) . Some reports even suggest that its eradication may be the single most effective step in HIV incidence reduction (Bowden and Garnett 1999, Sorvillo et al. 2001) .
Both, controversial findings on the use of benznidazole and nifurtimox for the treatment of trypanosomiasis (Cancado 2002, Coura and de Castro 2002) and the increase in the recognition of metronidazole-resistant trichomoniasis (Crowell et al. 2003) justify the screening of new antiparasitic agents. During our investigations on the N-substituted homoallylamine (Kouznetsov et al. 1998a, b) we found that diverse homoallylamines containing aryl or heteroaryl rings at the Skóra Stefañski DOI: 10.2478/s11686-006-0010-zC-4 of butene displayed significant activity (MIC < 50 µg/ml) against some pathogenic dermatophytes (Urbina et al. 2000 , Vargas et al. 2003 . This fact encouraged us to investigate other possible antimicrobial activities of these homoallylamines and related hydroquinoline and quinoline derivatives. So, we have recently reported the antiparasitic properties of some 5-nitro(amino)-2-pyridylquinoline derivatives (Kouznetsov et al. 2004) . Among quinolines, Jonckers et al. (2002) have assayed some neocryptolepine derivatives that appear as promising antimalarial and antitrypanosomal agents.
In this paper we report the in vitro antichagasic and trichomonacidal activities, and unspecific cytotoxicity against macrophages of the previously synthesized (Urbina et al. 2000 , Vargas et al. 2003 
Materials and methods

Anti-Trypanosoma cruzi epimastigote assays
The activity of the compounds was determined on epimastigotes of T. cruzi strain Y, grown at 28°C in liver infusion tryptose (LIT) medium supplemented with 10% of heat inactivated fetal calf serum as described (Muelas-Serrano et al. 2000) . Briefly, 24 well plates (Costar, Corning NY) were seeded with 900 µl of a homogeneous early log phase culture containing 500,000 epimastigotes/ml. Compounds dissolved in dimethyl sulfoxide (DMSO) were then added in triplicate at final concentrations of 100, 10 and 1 µg/ml. After 96 h of incubation at 28°C, 100 µl of a 2.5 mg/ml of MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, containing 0.22 mg/ml of PMS (phenazine methosulfate) to enhance the formazan yield (Cedillo-Rivera et al. 1992, Hattori and Nakanishi 1995) were added. After 75 min, formazan crystals were dissolved with 1 ml of a 10% sodium dodecyl sulfate (SDS) -0.01 N HCl solution, and absorbances were read at 595 nm in a plate reader EL × 800 from Bio-Tek Instruments Inc. Antiepimastigote (AE) activity was calculated as: % AE = 100 × (ODc-ODcm)-(ODe-ODec)/(ODc-ODcm) where ODc represents the mean of optical densities for control wells and ODe, the mean for experimental wells. Optical density of medium (ODcm) and of every compound (ODec) were respectively subtracted. Nifurtimox (Lampit from Bayer, Argentina) was used as reference drug.
Anti-Trichomonas vaginalis assays
Trichomonas vaginalis strain JH31A No. 4 was cultured at 37°C with 5% CO 2 in TYM (Trypticase-Yeast extract-Maltose) medium supplemented with 10% of heat inactivated equine serum. The assays were carried out using glass tubes containing 100,000 protozoa/ml in a final volume of 2 ml. Compounds were added to the cultures 6 h after seeding. For each concentration assayed (100, 10 and 0.1 µg/ml), there were three experimental and six growth controls. Viable protozoa were assessed at 24 h after incubation in the presence of the compounds by counting in an haemocytometer. Results are expressed both as percentages of inhibition (cytostatic activity) and percentages of reduction (cytocidal activity) with respect to controls. Metronidazole (Rhône Poulenc, Courbevoie, France) was used as reference drug.
Toxicity assays
Murine macrophages J774 were seeded (70,000 cells/well) in 96 well flat bottom microplates (Sarstedt, Sarstedt Inc., Newton, NC) with 200 µl of RPMI 1640 medium (Sigma) supplemented with 20% heat inactivated fetal calf serum. Cells were allowed to attach for 24 h in a humidified 5% CO 2 /95% air atmosphere at 37°C. Then, cells were exposed to the compounds (100, 10 and 1 µg/ml) for 24 h. Afterwards, cells were washed with PBS and incubated (37°C) with MTT 0.4 mg/ml for 60 min. Formazan was dissolved with DMSO (100 µl) and optical densities were measured as above. Each concentration was assayed three times and six growth controls were used in each test. Cytotoxicity percentages (%C) were determined as: %C = 100-(ODd-ODdm)/(ODc-ODcm) × 100 where ODd is the mean of OD595 of wells with macrophages and different concentrations of the compounds; ODdm is the 
Results
In order to simplify the results, only antiparasitic activity above 50% and unspecific toxicity below 50% are summarized. The in vitro efficacy against epimastigotes of T. cruzi is shown in Table I . The specific activity against T. vaginalis (Table II) is expressed as cytostatic activity (growth inhibition), or cytocidal activity (percentage of reduction with respect to control) in brackets. Unspecific cytotoxicity to macrophages (Table III) is expressed as cytotoxicity percentage.
Discussion
In the course of a screening program for new antifungal compounds, we have recently reported (Urbina et al. 2000 , Vargas et al. 2003 ) the interesting antifungal properties displayed by some homoallylamines, tetrahydroquinolines and quinolines.
Homoallylamines could serve as versatile precursors to obtain 2-substituted 4-methylquinolines via tetrahydroquinolines. 100 µg/ml 50-75 15, 20, 28, 37, 38, 56, 59, 62, 64 > 75 1-14, 16, 17, 19, 21-27, 29, 30-36, 39-55, 57, 58, 60, 61, 63, 65, 67-69 10 µg/ml 50-75 2, 3, 7, 10, 15, 16, 22, 26, 44, 47, 48, 50-52, 55, 57, 58, 59, 65 > 75 5, 9, 25, 49, 63, 64, 68 , 69 1 µg/ml 50-75 25
Nifurtimox was assayed at 10, 2.5 and 0.5 µg/ml and reached 100, 88 and 54%, respectively. 100 µg/ml 50-75 10, 15, 17, 18, 21, 23, 25-27, 31, 45, 50, 55, 62, 66, 67 > 75 1-4, (5), (6), 7, 8, (9), 11, (12), (13), 14, (16), 19, 20, 22, (24), (28), 29, 30, 32-39, (40), 41, (42), 43, 44, 47-49, (51-54), 56, 57, (58), 59-61, (63), 64, 65, 68, 69 10 µg/ml 50-75 5, 6, 28, 29, 32, 34-36, 39, 40, 49, 53, 57-60, 63, 64, 65, 68, 69 > 75 42 Metronidazole was assayed at 2, 1 and 0.5 µg/ml and reached cytocidal activity of 100, 97.9 and 83.5, respectively. 100 µg/ml < 25 3, 11, 18, 20-23, 26, 29, 34, 37, 41, 43, 46, 59, 66 25-50 1, 2, 4, 8, 10, 12, 14, 19, 25, 27, 28, 35, 39, 44, 45, 49, 60, 64, 67 10 µg/ml < 25 1-4, 6, 8, 10-44, 46-63, 65-67, 69 25-50 5, 7, 9, 45, 64, 68 1 µg/ml < 25 1-9, 11-44, 46-50, 52-69 25-50 10, 45, 51 some have showed antileishmanial activity (Fournet et al. 1993) . Looking for other antiparasitic effect, trypanocidal and trichomonacidal activities were assayed. Results showed that most of the compounds tested (Table  I ) exhibit a trypanocidal activity of 75 to 100% at the higher concentration assayed (100 µg/ml). Since this activity could be due to unspecific cytotoxicity we compared unspecific cytotoxicity (%C) (Table III) with anti-epimastigote activity (%AE) ( Table I) for each compound.
Some compounds (1-4, 8, 10, 11, 14, 21-23, 25-27, 29, 34, 35, 39, 41, 43-46, 49 ) present intrinsic trypanocidal activity at 100 µg/ml since their %C at this concentration is much lower than their %AE (%C<50, %AE>75), showing homoallylamines 22 and 29 the most interesting trypanocidal activity without cytotoxicity at this concentration.
Twenty-eight compounds (2, 3, 5, 7, 9, 10, 15, 16, 19, 22, 25, 26, 35, 44, 47-52, 55, 57-59, 63-65, 68 and 69) retained at least 50% of antichagasic activity at 10 µg/ml, at this concentration none unspecific cytotoxicity was shown for these compounds in most cases. Both, the homoallylamine derivative 25 (%C = 5.2) and the quinoline derivative 63 (%C = 0) showed trypanocidal activity higher than 90% at 10 µg/ml being the most interesting compounds at this concentration. Compound 25 retained even 60% of trypanocidal activity at the lower dose assayed (1 µg/ml).
Regarding trichomonacidal assays, many compounds exhibit cytocidal activity or at least an important cytostatic activity ($75%) at 100 µg/ml: 1-9, 11-14, 16, 19, 20, 22, 24, 27-30, 32-37, 39-44, 47-49, 51-54, 56-61, 63-65, 68 and 69. However, if we discarded those with > 25% of unspecific cytotoxicity, only compounds 3, 11, 22, 29, 34, 41, 43 and 59 maintain an intrinsic trichomonacidal activity.
Although the antiparasitic activities were not comparable to those of the standard drugs, nifurtimox and metronidazole, some of the compounds could be useful as lead structures for further development.
